UNRESECTABLE BREAST CANCER
Clinical trials for UNRESECTABLE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BREAST CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing whether a combination of two existing cancer drugs, tucatinib and trastuzumab, can help control advanced breast cancer that has a specific genetic change (an ERBB3/HER3 mutation) but is not the typical HER2-positive type. It is for people whose cancer has sp…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 03, 2026 19:40 UTC
-
Tracking a new hope for Tough-to-Treat breast cancer
Disease control Recruiting nowThis study aims to understand how well a targeted drug called trastuzumab deruxtecan works for people with advanced, hard-to-treat breast cancer that has a specific marker (HER2-low). It will follow over 1,100 patients in Europe who are already receiving this drug or standard che…
Matched conditions: UNRESECTABLE BREAST CANCER
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Blood test could tell doctors when to switch cancer drugs
Disease control Recruiting nowThis study is testing whether a simple blood test taken early in treatment can help doctors make better decisions for patients with advanced breast cancer. Patients will receive standard first-line treatment, then have their blood tested after two weeks. If the test shows the tre…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC